NeuroMetrix, Inc. Announces Fourth Quarter 2018 Financial Results Conference Call
January 15 2019 - 02:00PM
NeuroMetrix, Inc. (NASDAQ: NURO) will issue its fourth quarter
2018 financial results on Thursday morning January 24, 2019. A
conference call will be held shortly afterwards at 8:00 a.m.
Eastern. The call may be accessed in the United States at
844-787-0799, international at 661-378-9630. The confirmation code
is 1262224. A replay will be available starting two hours after the
call at 855-859-2056 United States and 404-537-3406 international
using confirmation code 1262224. It will remain available for one
week. The earnings release will be available on the Company's
website www.NeuroMetrix.com under "Investor Relations".
About NeuroMetrix
NeuroMetrix is a commercial stage, innovation driven
healthcare company combining neurostimulation and digital medicine
to address chronic health conditions including chronic pain, sleep
disorders, and diabetes. The Company has two primary products.
Quell® is an over-the-counter wearable therapeutic device for
chronic pain. DPNCheck® is a rapid point-of-care test
for diabetic neuropathy which is the most common
long-term complication of Type 2 diabetes. For more information,
please visit http://www.neurometrix.com.
NeuroMetrix, Inc. Thomas T. Higgins, 781-314-2761 SVP and Chief
Financial Officer neurometrix.ir@neurometrix.com
Source: NeuroMetrix, Inc.
NeuroMetrix (NASDAQ:NURO)
Historical Stock Chart
From Feb 2024 to Mar 2024
NeuroMetrix (NASDAQ:NURO)
Historical Stock Chart
From Mar 2023 to Mar 2024